跳至主要内容
临床试验/CTRI/2024/07/069824
CTRI/2024/07/069824已完成4 期

To study the effect of probiotics Supplementation on Morbidities in Indian Preterm Neonates.

RNT Medical College & Hospital, Udaipur1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2024年7月15日最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
300
试验地点
1
主要终点
suspected or confirmed positive Bell stage 2 or more

研究概览

简要总结

Probiotic supplementation in preterm neonates was safe and associated with modest improvements in weight at discharge and follow-up. However, it did not significantly impact NEC, sepsis, mortality, or hospital stay, with gestational age remaining the strongest predictor of outcomes. Probiotics can be safely incorporated into NICU care for preterm neonates to support growth, but their greatest benefit is likely in extremely preterm and high-risk populations.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
1.00 Day(s) 至 7.00 Day(s)(—)
性别
All

入选标准

  • Gestation Neonates born before less than 34weeks Age at recruitment within 7 days of life Weight low birth weight less than 1800 grams.

排除标准

  • Malformation of the gut (omphalocele, gastroschisis, intestinal atresia) Neonates with central venous catheter Any condition that prevents oral or nasogastric intake.

结局指标

主要结局

suspected or confirmed positive Bell stage 2 or more

时间窗: Everyday until the period of hospital stay and further upto 6 weeks of life

次要结局

  • Culture positive sepsis: blood culture positive(Clinical sepsis: clinical features of sepsis without)

研究者

发起方
RNT Medical College & Hospital, Udaipur
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Nehal Athreyi R

RNT Medical College & Hospital, Udaipur

研究点 (1)

Loading locations...

相似试验